中山康方生物醫(yī)藥有限公司
陳晨博士在生物制藥及全球商務(wù)拓展領(lǐng)域深耕多年,在研發(fā)外部創(chuàng)新、管線合作、商務(wù)拓展等方面有著扎實(shí)的經(jīng)
驗(yàn)和實(shí)踐成果。在加入公司之前,陳博士曾擔(dān)任默克雪蘭諾(‘默克’)醫(yī)藥研發(fā)外部創(chuàng)新亞太區(qū)負(fù)責(zé)人,期間通過(guò)聯(lián)絡(luò)中國(guó)和亞太地區(qū)制藥公司、生物技術(shù)公司、專業(yè)投資人以及卓越的學(xué)術(shù)研究中心,推動(dòng)與默克研發(fā)管線的合作機(jī)會(huì)。陳博士是默克亞洲和中國(guó)研發(fā)中心的領(lǐng)導(dǎo)成員之一,也是默克在華拓展腫瘤事業(yè)和創(chuàng)新合作的核心成員之一。陳博士從英國(guó)埃塞克斯大學(xué)獲得細(xì)胞和分子生物學(xué)學(xué)士學(xué)位、英國(guó)諾丁漢大學(xué)癌癥免疫治療碩士學(xué)位、英國(guó)帝國(guó)理工學(xué)院生物化學(xué)博士學(xué)位。
Dr. Michael Chen has dedicated himself to bio-pharmaceutical industry and global business development for years and has extensive experience and practical achievements in external innovation, pipeline cooperation and business development. Before joining Akeso, Dr. Chen worked as Head of External Innovation APAC for Merck KGaA. Dr. Chen led collaborations with local pharmaceutical/biotech companies, investor groups and academic institutions in China and APAC areas. Meanwhile, Dr. Chen was also responsible for the international business development department of Merck in China and APAC areas, carrying out a variety of internal and external business cooperation. Dr. Chen was also one of the leading members of Merck Asia and China research and development center, and one of the core members for expanding Merck’s oncology business and innovation collaboration in China.
Dr. Chen received his bachelor’s degree of cell and molecular biology from University of Essex, a master’s degree in cancer immunotherapy from University of Nottingham and a Ph.D. degree in biochemistry from Imperial College London.